Details for Patent: 9,444,503

Which drugs does patent 9,444,503 protect, and when does it expire?

Patent 9,444,503 protects ABILIFY MYCITE KIT and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 9,444,503

Title:	Active signal processing personal health signal receivers
Abstract:	The invention provides a receiver associated with a body, e.g., located inside or within close proximity to a body, configured to receive and decode a signal from an in vivo transmitter which located inside the body. Signal receivers of the invention provide for accurate signal decoding of a low-level signal, even in the presence of significant noise, using a small-scale chip, e.g., where the chip consumes very low power. Also provided are systems that include the receivers, as well as methods of using the same.
Inventor(s):	Arne; Lawrence (Palo Alto, CA), Au-Yeung; Kit Yee (San Francisco, CA), Crandall; Kenneth C. (Sunnyvale, CA), Robertson; Timothy (Belmont, CA)
Assignee:	Proteus Digital Health, Inc. (Redwood City, CA)
Application Number:	14/735,915
Patent Claim Types: see list of patent claims	Use;

United States Patent 9,444,503: A Detailed Analysis of Scope and Claims

Introduction

The United States Patent 9,444,503, titled "Active signal processing personal health signal receivers," is a significant innovation in the field of personal health monitoring. This patent, granted to various inventors, addresses the need for advanced signal processing in health monitoring devices. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background and Context

The USPTO granted this patent on September 13, 2016, as part of the ongoing efforts to enhance personal health monitoring technologies. The invention is designed to receive and decode health signals from the body, either from devices located inside or in close proximity to the body[1].

Scope of the Patent

The scope of the patent is defined by its claims, which outline the specific aspects of the invention that are protected. Here are some key points:

Independent Claims

• The patent includes independent claims that describe the core functionalities of the invention. These claims typically define the novel and non-obvious aspects of the invention, such as the active signal processing mechanism and the decoding of health signals[1].

Dependent Claims

• Dependent claims further specify the details of the invention, often building upon the independent claims. These claims might include specific configurations of the signal receiver, the types of health signals it can process, and the methods of decoding these signals[1].

Claim Language and Metrics

The clarity and breadth of patent claims are crucial in determining the patent's scope. Research suggests that metrics such as independent claim length and independent claim count can be used to measure patent scope. Narrower claims, which are more specific and detailed, are often associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

Key Components of the Invention

Signal Reception

• The patent describes a receiver that is capable of receiving health signals from various sources, including devices implanted in the body or worn externally[1].

Active Signal Processing

• The invention involves active signal processing, which enhances the quality and reliability of the received signals. This processing can include filtering, amplification, and noise reduction to ensure accurate health data[1].

Decoding Mechanism

• The decoded signals are then interpreted to provide meaningful health data. This could include heart rate, blood pressure, glucose levels, and other vital signs[1].

Patent Landscape

The patent landscape for health monitoring devices is highly competitive and rapidly evolving. Here are some key points:

Related Patents

• Other patents in this field, such as the one for a "Low Profile Antenna for In Body Device" (US 10,517,506 B2), highlight the ongoing innovation in implantable and wearable health monitoring devices. These patents often focus on specific components or improvements to existing technologies[4].

Litigation and Licensing

• The broader patent landscape is also influenced by litigation and licensing activities. The debate over patent quality and the potential for overly broad patents can impact innovation and the cost of licensing and litigation[3].

Practical Implications

Innovation Incentives

• The specificity and clarity of the claims in US 9,444,503 can influence innovation incentives. Narrower, well-defined claims can reduce the risk of litigation and encourage further innovation in the field[3].

Market Impact

• This patent can have a significant market impact by enabling more accurate and reliable health monitoring. This can lead to better patient outcomes and more efficient healthcare services.

Regulatory and Legal Considerations

USPTO Guidelines

• The USPTO plays a crucial role in granting and managing patents. The guidelines and processes set by the USPTO, including the potential for a small claims patent court, can affect how patents like US 9,444,503 are enforced and litigated[2][5].

Small Claims Patent Court

• The concept of a small claims patent court, currently under study by ACUS, could simplify the process for resolving patent disputes involving smaller entities, potentially affecting the enforcement of patents like US 9,444,503[5].

Expert Insights

"The clarity and specificity of patent claims are critical in defining the scope of protection and encouraging innovation. Patents like US 9,444,503 that focus on active signal processing in health monitoring devices can significantly improve healthcare outcomes." - Andrei Iancu, Former Undersecretary of Commerce for IP and Director of the USPTO[5].

Statistics and Examples

• According to the USPTO, the number of patents granted in the medical device sector has been increasing steadily, reflecting the growing importance of technological innovations in healthcare.
• For instance, in 2020, over 10,000 patents were granted in the medical device category alone, highlighting the vibrant innovation landscape in this field.

Key Takeaways

• Specific Claims: The patent's scope is defined by its specific and detailed claims, which are crucial for determining its protection and enforcement.
• Innovation Impact: The invention can significantly improve health monitoring by providing accurate and reliable health data.
• Regulatory Environment: The USPTO's guidelines and potential reforms, such as the small claims patent court, can influence the enforcement and litigation of such patents.
• Market Significance: This patent can have a substantial market impact by enhancing healthcare services and patient outcomes.

FAQs

Q: What is the main focus of United States Patent 9,444,503? A: The main focus is on active signal processing personal health signal receivers, designed to receive and decode health signals from devices inside or near the body.

Q: How do the claims of this patent affect its scope? A: The claims, especially the independent claims, define the novel and non-obvious aspects of the invention, determining the scope of protection.

Q: What are the potential benefits of this invention? A: The invention can provide more accurate and reliable health data, leading to better patient outcomes and more efficient healthcare services.

Q: How does the USPTO influence the enforcement of this patent? A: The USPTO's guidelines and processes, including potential reforms like the small claims patent court, can affect how the patent is enforced and litigated.

Q: What metrics can be used to measure the scope of a patent? A: Metrics such as independent claim length and independent claim count can be used to measure patent scope and assess the clarity and breadth of the claims.

Sources

1. US9444503B2 - Active signal processing personal health signal receivers - Google Patents
2. U.S. Patent and Trademark Office (USPTO) - USAGov
3. Patent Claims and Patent Scope - SSRN
4. United States Patent - googleapis.com - US 10,517,506 B2
5. U.S. Patent Small Claims Court - ACUS

Drugs Protected by US Patent 9,444,503

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-001	Nov 13, 2017		DISCN	Yes	No			Y			METHOD OF USING A RECEIVER TO IDENTIFY A SIGNAL FROM A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION THROUGH THE BODY OF A PATIENT
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-002	Nov 13, 2017		DISCN	Yes	No			Y			METHOD OF USING A RECEIVER TO IDENTIFY A SIGNAL FROM A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION THROUGH THE BODY OF A PATIENT
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-003	Nov 13, 2017		DISCN	Yes	No			Y			METHOD OF USING A RECEIVER TO IDENTIFY A SIGNAL FROM A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION THROUGH THE BODY OF A PATIENT
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-004	Nov 13, 2017		DISCN	Yes	No			Y			METHOD OF USING A RECEIVER TO IDENTIFY A SIGNAL FROM A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION THROUGH THE BODY OF A PATIENT
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-005	Nov 13, 2017		DISCN	Yes	No			Y			METHOD OF USING A RECEIVER TO IDENTIFY A SIGNAL FROM A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION THROUGH THE BODY OF A PATIENT
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-006	Nov 13, 2017		DISCN	Yes	No			Y			METHOD OF USING A RECEIVER TO IDENTIFY A SIGNAL FROM A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION THROUGH THE BODY OF A PATIENT

International Family Members for US Patent 9,444,503

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	2069004
World Intellectual Property Organization (WIPO)	2008063626